{ "labelLang" : "hun", "responseDate" : "2024-03-29 15:33", "content" : { "otype" : "JournalArticle", "mtid" : 31288415, "status" : "VALIDATED", "published" : true, "comment" : "Import hibák 2020-06-15 09:08\nA besorolást az importban szereplő adat alapján nem lehetett meghatározni a következő elemhez: Review; Early Access\nExport Date: 23 April 2020 \n CODEN: EODSA\nDivision of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium \n Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, Belgium \n Cited By :1 \n Export Date: 3 May 2020 \n CODEN: EODSA \n Correspondence Address: Scheen, A.J.; Department of Medicine, CHU Sart Tilman (B35), B-4000, Belgium; email: andre.scheen@chu.ulg.ac.be \n Chemicals/CAS: canagliflozin, 842133-18-0, 928672-86-0; dapagliflozin, 461432-26-8; empagliflozin, 864070-44-0; ertugliflozin, 1210344-57-2, 1210344-83-4; ipragliflozin, 761423-87-4; luseogliflozin, 898537-18-3; tofogliflozin, 1201913-82-7, 903565-83-3\nDivision of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium \n Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, Belgium \n Cited By :1 \n Export Date: 7 May 2020 \n CODEN: EODSA \n Correspondence Address: Scheen, A.J.; Department of Medicine, CHU Sart Tilman (B35), B-4000, Belgium; email: andre.scheen@chu.ulg.ac.be \n Chemicals/CAS: canagliflozin, 842133-18-0, 928672-86-0; dapagliflozin, 461432-26-8; empagliflozin, 864070-44-0; ertugliflozin, 1210344-57-2, 1210344-83-4; ipragliflozin, 761423-87-4; luseogliflozin, 898537-18-3; tofogliflozin, 1201913-82-7, 903565-83-3\nDivision of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium \n Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, Belgium \n Cited By :1 \n Export Date: 22 June 2020 \n CODEN: EODSA \n Correspondence Address: Scheen, A.J.; Department of Medicine, CHU Sart Tilman (B35), B-4000, Belgium; email: andre.scheen@chu.ulg.ac.be \n Chemicals/CAS: canagliflozin, 842133-18-0, 928672-86-0; dapagliflozin, 461432-26-8; empagliflozin, 864070-44-0; ertugliflozin, 1210344-57-2, 1210344-83-4; ipragliflozin, 761423-87-4; luseogliflozin, 898537-18-3; tofogliflozin, 1201913-82-7, 903565-83-3\nDivision of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium \n Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, Belgium \n Cited By :1 \n Export Date: 29 June 2020 \n CODEN: EODSA \n Correspondence Address: Scheen, A.J.; Department of Medicine, CHU Sart Tilman (B35), B-4000, Belgium; email: andre.scheen@chu.ulg.ac.be \n Chemicals/CAS: canagliflozin, 842133-18-0, 928672-86-0; dapagliflozin, 461432-26-8; empagliflozin, 864070-44-0; ertugliflozin, 1210344-57-2, 1210344-83-4; ipragliflozin, 761423-87-4; luseogliflozin, 898537-18-3; tofogliflozin, 1201913-82-7, 903565-83-3\nDivision of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium \n Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, Belgium \n Cited By :1 \n Export Date: 24 August 2020 \n CODEN: EODSA \n Correspondence Address: Scheen, A.J.; Department of Medicine, CHU Sart Tilman (B35), B-4000, Belgium; email: andre.scheen@chu.ulg.ac.be \n Chemicals/CAS: canagliflozin, 842133-18-0, 928672-86-0; dapagliflozin, 461432-26-8; empagliflozin, 864070-44-0; ertugliflozin, 1210344-57-2, 1210344-83-4; ipragliflozin, 761423-87-4; luseogliflozin, 898537-18-3; tofogliflozin, 1201913-82-7, 903565-83-3\nDivision of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium \n Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, Belgium \n Cited By :1 \n Export Date: 10 September 2020 \n CODEN: EODSA \n Correspondence Address: Scheen, A.J.; Department of Medicine, CHU Sart Tilman (B35), B-4000, Belgium; email: andre.scheen@chu.ulg.ac.be \n Chemicals/CAS: canagliflozin, 842133-18-0, 928672-86-0; dapagliflozin, 461432-26-8; empagliflozin, 864070-44-0; ertugliflozin, 1210344-57-2, 1210344-83-4; ipragliflozin, 761423-87-4; luseogliflozin, 898537-18-3; tofogliflozin, 1201913-82-7, 903565-83-3\nDivision of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium \n Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, Belgium \n Cited By :3 \n Export Date: 9 July 2021 \n CODEN: EODSA \n Correspondence Address: Scheen, A.J.; Department of Medicine, CHU Sart Tilman (B35), B-4000, Belgium; email: andre.scheen@chu.ulg.ac.be \n Chemicals/CAS: canagliflozin, 842133-18-0, 928672-86-0; dapagliflozin, 461432-26-8; empagliflozin, 864070-44-0; ertugliflozin, 1210344-57-2, 1210344-83-4; ipragliflozin, 761423-87-4; luseogliflozin, 898537-18-3; tofogliflozin, 1201913-82-7, 903565-83-3; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors", "unhandledTickets" : 0, "deleted" : false, "lastRefresh" : "2023-10-17T09:16:39.401+0000", "lastModified" : "2020-09-01T18:39:36.742+0000", "created" : "2020-04-23T11:20:40.521+0000", "creator" : { "otype" : "Admin", "mtid" : 10039043, "link" : "/api/admin/10039043", "label" : "Milánkovics Róbert (PTE ÁOK admin 4)", "familyName" : "Milánkovics", "givenName" : "Róbert", "published" : true, "oldId" : 10039043, "snippet" : true }, "lastDuplumOK" : "2023-07-25T12:56:06.586+0000", "lastDuplumSearch" : "2023-07-25T12:56:06.586+0000", "validated" : "2020-09-01T18:39:25.230+0000", "validator" : { "otype" : "Admin", "mtid" : 565, "link" : "/api/admin/565", "label" : "WoS import (admin)", "familyName" : "WoS", "givenName" : "import", "published" : true, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 1134514, "link" : "/api/subtype/1134514", "label" : "Összefoglaló cikk (Folyóiratcikk)", "name" : "Összefoglaló cikk", "nameEng" : "Survey paper", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 102, "published" : true, "oldId" : 1134514, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Scheen, A.J.", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 91485349, "link" : "/api/authorship/91485349", "label" : "Scheen, A.J.", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "corresponding" : false, "familyName" : "Scheen", "givenName" : "A.J.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true } ], "title" : "Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 16855648, "link" : "/api/publicationidentifier/16855648", "label" : "DOI: 10.1080/14740338.2020.1733967", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1080/14740338.2020.1733967", "realUrl" : "https://doi.org/10.1080/14740338.2020.1733967", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 16855649, "link" : "/api/publicationidentifier/16855649", "label" : "WoS: 000518411600001", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000518411600001", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/000518411600001", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 16855647, "link" : "/api/publicationidentifier/16855647", "label" : "Scopus: 85080865563", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85080865563", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85080865563", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 16897981, "link" : "/api/publicationidentifier/16897981", "label" : "PubMed: 32083962", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "32083962", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32083962&dopt=Abstract", "published" : false, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 10009574, "link" : "/api/journal/10009574", "label" : "EXPERT OPINION ON DRUG SAFETY 1474-0338 1744-764X", "pIssn" : "1474-0338", "eIssn" : "1744-764X", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 10009574, "snippet" : true }, "volume" : "19", "issue" : "3", "firstPage" : "243", "lastPage" : "256", "firstPageOrInternalIdForSort" : "243", "pageLength" : 14, "publishedYear" : 2020, "digital" : null, "printed" : null, "sourceYear" : 2020, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-10-17", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 10, "citedCount" : 10, "ratings" : [ { "otype" : "SjrRating", "mtid" : 10991750, "link" : "/api/sjrrating/10991750", "label" : "sjr:Q1 (2020) Scopus - Medicine (miscellaneous) EXPERT OPINION ON DRUG SAFETY 1474-0338", "listPos" : 491, "rankValue" : 0.24, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 2701, "link" : "/api/classificationexternal/2701", "label" : "Scopus - Medicine (miscellaneous)", "published" : true, "oldId" : 2701, "snippet" : true }, "ranking" : "Q1", "calculation" : "DIRECT", "published" : true, "snippet" : true } ], "ratingsForSort" : "Q1", "hasCitationDuplums" : false, "userChangeableUntil" : "2020-07-22T11:21:06.298+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 16, "ownerInstituteCount" : 73, "directInstituteCount" : 0, "authorCount" : 1, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/31288415", "label" : "Scheen A.J.. Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease. (2020) EXPERT OPINION ON DRUG SAFETY 1474-0338 1744-764X 19 3 243-256", "template" : "